Milind Deshpande
2018
In 2018, Milind Deshpande earned a total compensation of $2.1M as Former Director and Chief Executive Officer at Achillion Pharmaceuticals, a 6% decrease compared to previous year.
Compensation breakdown
| Option Awards | $1,295,616 |
|---|---|
| Salary | $227,888 |
| Other | $545,959 |
| Total | $2,069,463 |
Deshpande received $1.3M in option awards, accounting for 63% of the total pay in 2018.
Deshpande also received $227.9K in salary and $546K in other compensation.
Rankings
In 2018, Milind Deshpande's compensation ranked 5,551st out of 14,244 executives tracked by ExecPay. In other words, Deshpande earned more than 61.0% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 5,551 out of 14,244 | 61st |
Division Manufacturing | 2,093 out of 5,759 | 64th |
Major group Chemicals And Allied Products | 772 out of 2,122 | 64th |
Industry group Drugs | 646 out of 1,811 | 64th |
Industry Pharmaceutical Preparations | 498 out of 1,385 | 64th |
Source: SEC filing on April 15, 2019.
Deshpande's colleagues
We found five more compensation records of executives who worked with Milind Deshpande at Achillion Pharmaceuticals in 2018.
2018
Joseph Truitt
Achillion Pharmaceuticals
Chief Executive Officer
2018
Steven Zelenkofske
Achillion Pharmaceuticals
Chief Medical Officer
2018
Paul Firuta
Achillion Pharmaceuticals
Chief Operating Officer
2018
Mary Fenton
Achillion Pharmaceuticals
Chief Financial Officer
2018
Anthony Gibney
Achillion Pharmaceuticals